会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SENSITIZATION OF CANCER CELLS TO TREATMENT
    • 癌细胞对治疗的敏感性
    • WO2012106379A1
    • 2012-08-09
    • PCT/US2012/023402
    • 2012-01-31
    • PARINGENIX, INC.MARCUS, Stephen
    • MARCUS, Stephen
    • A61K31/727
    • A61K31/727A61K31/337A61K31/555A61K31/7068A61K45/06A61K2300/00
    • The present application provides methods for the treatment of cancer, comprising administering substantially non-anticoagulant 2-O, 3-O desulfated heparin to patients suffering from cancer that is, or can become resistant to, cancer treatment, such as chemotherapy, targeted cancer therapy, or radiation therapy. The compositions can be administered to sensitize, or to reverse resistance to, cancer treatment, and can be administered alone or in combination with cancer treatment to subjects with solid tumors including, but not limited to, pancreatic, breast, renal, colorectal, gastric, or esophageal cancer, and subjects with hematologic malignancies, including but not limited to leukemia and lymphoma.
    • 本申请提供了用于治疗癌症的方法,其包括向患有癌症的癌症患者施用基本上非抗凝血的2-O,3-O脱硫酸肝素,所述癌症治疗或可能对癌症治疗如化疗,靶向癌症治疗 ,或放射治疗。 可以施用组合物以敏化或抵抗癌症治疗的抗性,并且可以单独施用或与癌症治疗组合施用于具有实体瘤的受试者,包括但不限于胰腺,乳腺,肾脏,结肠直肠癌,胃癌, 或食管癌,以及具有血液恶性肿瘤的受试者,包括但不限于白血病和淋巴瘤。